Apogee Therapeutics (APGE) Earnings Date & Reports

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

APGE is expected to report earnings to fall 50.85% to -57 cents per share on May 19

Apogee Therapeutics APGE Stock Earnings Reports

Q1'25

Est.

$-0.58

Q4'24

Missed

by $0.56

Q3'24

Missed

by $0.30

Q2'24

Missed

by $0.08

Q1'24

Missed

by $0.15

The last earnings report on March 03 showed earnings per share of -117 cents, missing the estimate of -62 cents. With 312.33K shares outstanding, the current market capitalization sits at 2.15B.

View a ticker or compare two or three

Compare

APGE